Abrogation cell cycle checkpoint and inhibition of Chk1 kinase by UCN-01 in cancer cells treated with ara-C and other anticancer agents

被引：0
|
作者：
Shao, R. G.
Cao, C. X.
Pommier, Y.
机构：
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[2] NCI, NIH, Bethesda, MD 20892 USA
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2001年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：147 / 147
页数：1
相关论文
共 33 条
  • [1] The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01
    Graves, PR
    Yu, LJ
    Schwarz, JK
    Gales, J
    Sausville, EA
    O'Connor, PM
    Piwnica-Worms, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5600 - 5605
  • [2] Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells
    Shao, RG
    Cao, CX
    Pommier, Y
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (06) : 756 - 762
  • [3] Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells
    Yves POMMIER
    ActaPharmacologicaSinica, 2004, (06) : 54 - 60
  • [4] Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry
    Parsels, Leslie A.
    Tanska, Daria M.
    Parsels, Joshua D.
    Zabludoff, Sonya D.
    Cuneo, Kyle C.
    Lawrence, Theodore S.
    Maybaum, Jonathan
    Morgan, Meredith A.
    CELL CYCLE, 2016, 15 (05) : 730 - 739
  • [5] Modulation of cell cycle progression in human tumors: A pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850)
    Perez, Raymond P.
    Lewis, Lionel D.
    Beelen, Andrew P.
    Olszanski, Anthony J.
    Johnston, Nicholas
    Rhodes, C. Harker
    Beaulieu, Bernard
    Ernstoff, Marc S.
    Eastman, Alan
    CLINICAL CANCER RESEARCH, 2006, 12 (23) : 7079 - 7085
  • [6] Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
    Christopher Bryant
    Kirsten Scriven
    Andrew J Massey
    Molecular Cancer, 13
  • [7] Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
    Bryant, Christopher
    Scriven, Kirsten
    Massey, Andrew J.
    MOLECULAR CANCER, 2014, 13
  • [8] CELL-CYCLE ARREST AND GROWTH-INHIBITION BY THE PROTEIN-KINASE ANTAGONIST UCN-01 IN HUMAN BREAST-CARCINOMA CELLS
    SEYNAEVE, CM
    STETLERSTEVENSON, M
    SEBERS, S
    KAUR, G
    SAUSVILLE, EA
    WORLAND, PJ
    CANCER RESEARCH, 1993, 53 (09) : 2081 - 2086
  • [9] The influence of p53 transactivation and repression functions on abrogation of DNA damage-induced cell cycle arrest by UCN-01 in breast cancer cells.
    Kohn, EA
    Bresnick, E
    Direnzo, J
    Eastman, A
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6220S - 6220S
  • [10] Tumors driven by oncogene amplified extrachromosomal DNA (ecDNA) demonstrate enhanced sensitivity to cell cycle checkpoint kinase 1 (CHK1) inhibition
    Chowdhry, Sudhir
    Milutinovic, Snezana
    Tse, Edison
    Garcia, Salvador
    Perusse, Dean
    Ritland, Melissa
    Ko, Juyeon
    Wilkinson, Deepti
    Turner, Kristen
    Steffy, Auzon
    Plum, Joshua
    Ben Norman
    Pferdekamper, AnnMarie
    Meyer, Todd
    Liao, Debbie
    Elsdon, Rachelle
    Lange, Joshua
    Pinkerton, Anthony
    Hansen, Ryan
    Hassig, Christian
    Kasibhatla, Shailaja
    CANCER RESEARCH, 2023, 83 (07)
1234